Anzeige
Mehr »
Login
Samstag, 20.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Goldaktie: Eine Erfolgsgeschichte, die seinesgleichen sucht, startet gerade richtig durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PUTA | ISIN: US03815U3005 | Ticker-Symbol: UDJP
Tradegate
19.04.24
16:08 Uhr
0,321 Euro
-0,010
-3,02 %
1-Jahres-Chart
APPLIED DNA SCIENCES INC Chart 1 Jahr
5-Tage-Chart
APPLIED DNA SCIENCES INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,3100,33019.04.
0,3130,34919.04.

Aktuelle News zur APPLIED DNA SCIENCES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiAPPLIED DNA SCIENCES INC - 8-K, Current Report1
18.03.Applied DNA, Alphazyme partner on enzyme production scale-up5
18.03.Applied DNA Sciences, Inc.: Applied DNA Enters into Agreement with Alphazyme for Scale-Up Manufacturing of its Proprietary Linea RNAP, Progresses Towards GMP Linea IVT Production Start229- Project To Increase RNAP Manufacturing Capacity and Reduce Unit Costs of Goods -- Project Slated for Completion Coincident with Company's Planned Initiation of GMP Manufacturing for Linea DNA IVT...
► Artikel lesen
15.03.APPLIED DNA SCIENCES INC - S-1/A, General form for registration of securities2
14.03.Applied DNA Sciences, Inc.: Applied DNA to Showcase Linea DNA and Linea IVT Platforms at 24th Annual World Vaccine Congress429STONY BROOK, NY / ACCESSWIRE / March 14, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, will showcase its Linea IVT and Linea DNA platforms at...
► Artikel lesen
12.03.Applied DNA Sciences files to sell 11.29M shares of common stock for holders7
10.02.Applied DNA Sciences, Inc. (APDN) Q1 2024 Earnings Call Transcript2
08.02.Applied DNA Sciences Inc reports results for the quarter ended in December - Earnings Summary2
08.02.Recap: Applied DNA Sciences Q1 Earnings-
08.02.Applied DNA Sciences, Inc.: Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results446- Company On Track to Initiate First-Phase GMP Production Capacity for mRNA Critical Starting Materials During First Half of Calendar 2024, Projects Initial Facility Capacity to Enable up to $15 Million1...
► Artikel lesen
08.02.APPLIED DNA SCIENCES INC - 10-Q, Quarterly Report-
07.02.Earnings Preview For Applied DNA Sciences1
05.02.Applied DNA Sciences, Inc.: Applied DNA to Report First Quarter Fiscal 2024 Financial Results on Thursday, February 8, 2024438STONY BROOK, NY / ACCESSWIRE / February 5, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, today announced...
► Artikel lesen
02.02.Applied DNA Sciences, Inc.: Applied DNA Announces Closing of $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules578STONY BROOK, NY / ACCESSWIRE / February 2, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that it has closed its previously announced...
► Artikel lesen
31.01.Applied DNA announces $3.44M registered direct offering4
31.01.Applied DNA Sciences, Inc.: Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules357STONY BROOK, NY / ACCESSWIRE / January 31, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that it has entered into securities...
► Artikel lesen
31.01.APPLIED DNA SCIENCES INC - 8-K, Current Report2
26.01.APPLIED DNA SCIENCES INC - 10-K/A, Annual Report1
05.01.APPLIED DNA SCIENCES INC - 8-K, Current Report2
14.12.23Applied DNA Sciences, Inc.: Applied DNA Announces Joint Development Agreement to Integrate Linea IVT Platform into CDMO Kudo Biotechnology's mRNA Manufacturing Workflow394- Agreement Seeks to Leverage Linea IVT Platform to Enable Kudo Bio to Offer a Differentiated mRNA Manufacturing Capability with Mitigated dsRNA and Reduced Turnaround Times -STONY BROOK, NY and NEEDHAM...
► Artikel lesen
Seite:  Weiter >>
43 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,4